Skip to main content
SpringerLink
Log in

AURORA and JUPITER trials: Recognizing the limitations and expanding the benefits of statin treatment

  • Clinical Trials Report
  • Published:
Current Cardiology Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) [no authors listed]. Lancet 1994, 344:1383–1389.

  2. Sacks FM, Pfeffer MA, Moye LA, et al.: The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996, 335:1001–1009.

    Article  CAS  PubMed  Google Scholar 

  3. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group [no authors listed]. N Engl J Med 1998, 339:1349–1357.

  4. Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention Study (WOSCOPS). West of Scotland Coronary Prevention Study Group [no authors listed]. Circulation 1998, 97:1436–1439.

  5. Gotto AM, Boccuzzi SJ, Cook JR, et al.: Effect of lovastatin on cardiovascular resource utilization and costs in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). AFCAPS/TexCAPS Research Group. Am J Cardiol 2000, 86:1176–1181.

    Article  PubMed  Google Scholar 

  6. Colhoun HM, Betteridge DJ, Durrington PN, et al.: Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial. Lancet 2004, 364:685–696.

    Article  CAS  PubMed  Google Scholar 

  7. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. HPS Collaborative Group [no authors listed]. Lancet 2002, 360:7–22.

  8. Cannon CP, Braunwald E, McCabe CH, et al.: Intensive versus moderate lipid lowering with statins after acute coronary syndromes. Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators. N Engl J Med 2004, 350:1495–1504.

    Article  CAS  PubMed  Google Scholar 

  9. Khush KK, Waters DD, Bittner V, et al.: Effect of high-dose atorvastatin on hospitalizations for heart failure: subgroup analysis of the Treating to New Targets (TNT) study. Circulation 2007, 115:576–583.

    Article  CAS  PubMed  Google Scholar 

  10. Pedersen TR, Faergeman O, Kastelein JJP, et al.: High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial. JAMA 2005, 294:2437–2445.

    Article  CAS  PubMed  Google Scholar 

  11. Kjekshus J, Apetrei E, Barrios V, et al.: Rosuvastatin in older patients with systolic heart failure. N Engl J Med 2007, 357:2248–2261.

    Article  CAS  PubMed  Google Scholar 

  12. Tavazzi L, Maggioni AP, Marchioli R, et al.: Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Gissi-HF Investigators. Lancet 2008, 372:1223–1230.

    Article  PubMed  Google Scholar 

  13. Wanner C, Krane V, März W, et al.: Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. German Diabetes and Dialysis Study Investigators. N Engl J Med 2005, 353:238–248.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The University of Chicago Pritzker School of Medicine, 515 North State Street, Suite 2700, Chicago, IL, 60654, USA

    Michael H. Davidson

Authors
  1. Michael H. Davidson
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael H. Davidson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Davidson, M.H. AURORA and JUPITER trials: Recognizing the limitations and expanding the benefits of statin treatment. Curr Cardiol Rep 11, 401–403 (2009). https://doi.org/10.1007/s11886-009-0058-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11886-009-0058-0

Keywords

Search

Navigation